{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:17Z","timestamp":1776329837295,"version":"3.50.1"},"reference-count":12,"publisher":"Baskent University","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.6002\/ect.2021.0272","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T01:20:55Z","timestamp":1637716855000},"page":"1228-1231","source":"Crossref","is-referenced-by-count":2,"title":["Complete Remission of Refractory Immunothrombocytopenic Purpura After Tacrolimus Replacement With Cyclosporine in a Case of Living Related Liver Transplant"],"prefix":"10.6002","volume":"19","author":[{"given":"Masayoshi","family":"Hamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Kohrogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishiro","family":"Furuie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Anan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Schoettler M, Elisofon SA, Kim HB, et al. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015;62(2):214-218. doi:10.1002\/pbc.25215","DOI":"10.1002\/pbc.25215"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Domenech C, Mialou V, Galambrun C, et al. Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine. Transpl Int. 2008;21(4):397-399. doi:10.1111\/j.1432-2277.2007.00619.x","DOI":"10.1111\/j.1432-2277.2007.00619.x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Kaya Z, Egritas O, Dalgic B. Tacrolimus-induced autoimmune hemolytic anemia in a previously reported child with history of thrombocytopenia following liver transplant. Exp Clin Transplant. 2018;16(3):355-356. doi:10.6002\/ect.2017.0289","DOI":"10.6002\/ect.2017.0289"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Jonuleit H, Adema G, Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol. 2003;11(3-4):267-276. doi:10.1016\/S0966-3274(03)00057-1","DOI":"10.1016\/S0966-3274(03)00057-1"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Teachey DT, Jubelirer T, Baluarte HJ, Wade A, Manno CS. Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant. Pediatr Blood Cancer. 2009;53(6):1114-1116. doi:10.1002\/pbc.22183","DOI":"10.1002\/pbc.22183"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Klintmalm GB, Nashan B. The role of mTOR inhibitors in liver transplantation: reviewing the evidence. J Transplant. 2014;2014:845438. doi:10.1155\/2014\/845438","DOI":"10.1155\/2014\/845438"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kawahara T, Asthana S, Kneteman NM. m-TOR inhibitors: what role in liver transplantation? J Hepatol. 2011;55(6):1441-1451. doi:10.1016\/j.jhep.2011.06.015","DOI":"10.1016\/j.jhep.2011.06.015"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Dumortier J, Couchonnal E, Lacaille F, et al. mTOR inhibitors in pediatric liver transplant recipients. Clin Res Hepatol Gastroenterol. 2019;43(4):403-409. doi:10.1016\/j.clinre.2018.11.010","DOI":"10.1016\/j.clinre.2018.11.010"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Ho S, Clipstone N, Timmermann L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol. 1996;80(3 Pt 2):S40-45. doi:10.1006\/clin.1996.0140","DOI":"10.1006\/clin.1996.0140"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Zhu X, Imamura M, Hashino S, et al. Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells. Ann Hematol. 1995;71(6):301-306. doi:10.1007\/BF01697983","DOI":"10.1007\/BF01697983"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Watanabe S, Sakamoto R, Yamamoto H, et al. Pediatric pure red cell aplasia caused by tacrolimus after living-donor liver transplant. Exp Clin Transplant. 2020;18(7):838-841. doi:10.6002\/ect.2019.0075","DOI":"10.6002\/ect.2019.0075"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Assy N, Rosenthal E, Hazani A, Etzioni A, Baruch Y. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation. J Hepatol. 1997;27(5):934-936. doi:10.1016\/s0168-8278(97)80334-0","DOI":"10.1016\/S0168-8278(97)80334-0"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:03:22Z","timestamp":1637719402000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2021\/19\/11\/0\/1228\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0272","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}